Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . ] 178
batch____ bits E-value N 100.0% 1:178 MLRDKFIHYFQQWRERQLSRGEHWLAQHLAGRSPREKGMLLAAVVFLFSVGYYVLIWQPLSERIEQQETILQQLVAMNTRLKNAAPDIIAARKSATTTPAQVSRVISDSASAHSVVIRRIADRGENIQVWIEPVVFNDLLKWLNALDEKYALRVTQIDVSAAEKPGMVNVQRLEFGRG
1 UniRef50_Q46832 Putative general secretion ... 139 5e-32 1 100.0% 1:178 1:178 MLRDKFIHYFQQWRERQLSRGEHWLAQHLAGRSPREKGMLLAAVVFLFSVGYYVLIWQPLSERIEQQETILQQLVAMNTRLKNAAPDIIAARKSATTTPAQVSRVISDSASAHSVVIRRIADRGENIQVWIEPVVFNDLLKWLNALDEKYALRVTQIDVSAAEKPGMVNVQRLEFGRG
2 UniRef50_Q47VE3 General secretion pathway p... 135 8e-31 1 24.2% 25:177 1:155 ------------------------MKEWWQQLNSREQRLVAVMALVFIIFIFYSAIWQPINNSLTEANNKLAKQQELLTWVEENTALYHQAKRSGGKssGSISSVANRSAKTYKLTITRMQPQGDDLQVWIDSTPFTQLLFWLEHLANNEGLQVKAIDLTRGDSAGEVKVRRLHLTK-
3 UniRef50_Q7MPY7 Type II secretory pathway, ... 131 1e-29 1 28.0% 18:178 1:163 -----------------MTNLLNMFQAWWSSISQREQRLVVVCGVFGLIGLIYWGVLQPINARAEQAQLRIQSEKQLLSWVSEKADELTGLRASGGVsnQPLNQVIASSARQFKVELQRVQPRNEMLQVWVAPMPFNRLVDWLTFLKEKQGIEVEFMDIDRGKESGLVEVNRLQFKRG
4 UniRef50_P41851 General secretion pathway p... 129 5e-29 1 29.2% 18:178 1:164 -----------------MKELLAPVQAWWRSVTPREQKMVMGMGALTVLAIAYWGIWQPLSERTAQAQARLQTEKQLLSWVSENANDIVTLRAQgaPSDQPLNQVITNSTRQFNIELIRVQPRGEMMQVWIQPLPFSQLVSWIAYLQERQGVSVDAIDIDRGKVNGVVEVKRLQLKRG
5 UniRef50_Q089T8 General secretion pathway M... 129 6e-29 1 22.4% 22:177 1:158 ---------------------MENMRSWWQGLAIREQQLVGFCAAVLAIGIMYWGIWTPISNAQDTAERDNSAAQQTLNYVKQTANKIAGLKQAGAQarGSLSSVVNQTAGQYKLEITRMQPQGDKIQLWMDDVPFDALLGYLHDLVEQKGLTLDSVDLTESDVAGFVKVRRIQLSQ-
6 UniRef50_D0M419 General secretion pathway p... 129 6e-29 1 28.0% 18:178 1:163 -----------------MKNLISQAQAWWSSISQREQRLVMGCGAIAVIGIIYWGLLQPMSQRAELAQSRIQSEKQLLAWVQDKADGITALRKSSGVssQPLNQLVSSSARRYKVELIRVQPRNESVQVWIKPLAFNQLVDWLRYLKEQQGIEVEFLDIDRTDQAGMIDVNRLQFKRG
7 UniRef50_C8UAZ7 Type II secretion protein E... 120 2e-26 1 26.9% 22:177 1:159 ---------------------MNDLKKRLQYISPRERRLLTGCVALLVVAFVYYVFWLPWQVREDKWRTVIAREKYTVEWMKQQIPSIKKWEASMPEQGEplSAAVTQTSAAYGVSVTRLQPQGERLTVTLAPVEFNTLMQWLTQLHRRYRIRTVVFdvAQGNQPGHVTVNRLVLSR-
8 UniRef50_D0I3A1 General secretion pathway p... 120 2e-26 1 28.7% 22:178 1:161 ---------------------MKALIAYWQGLSRREQRLLGVASAVILLGTLYWGVVSPLQAKAEQAEQRLASERNLLSWVNSKAAEIEALRRATGssALPLNQSVTTTVKRYNLEIVRLQPQQEEIQVWLKPMPFNALISWLDDLSVNHGVQVKFIDVGKTETLGVVDVKRLQLGRG
9 UniRef50_P41850 General secretion pathway p... 118 8e-26 1 27.6% 22:177 2:161 ---------------------MDKLQGWWRSISAREQRLVAVGGSCLLIGFCYWIVWQPIANRIAERERQVLSQQQTLAWLKEKGEEVLAMQGGQgdTSGTLEGVVNRTAFNQKIKIARLQPQGQELQVWIDTVQFDDLLIWLASLADQHGVQVQVIEVAREnaPGLVKVRRLQLSR-
10 UniRef50_A6FGY6 General secretion pathway p... 116 3e-25 1 26.3% 25:176 1:154 ------------------------MKAYWQQLEQKEKQLISILIVTLVLACGYWLLWQPLQHDIINTQRKVNVQTQTLADVKVIGQKIMDLQGGkrSEAGDLNQLVSRSAARNQIVITRIQAKSDTLQIWIDDVNFNQFTAWLERLNKQYGIEIQNIDLSVSDAKGMVKVRRLQLG--
11 UniRef50_UPI0000E10E09 general secretion pathway p... 114 1e-24 1 29.5% 23:178 4:161 ----------------------QALSDWFSQLAPREQALLKVGSVILIIAGFYGLVWAPMNASIERETKLLAQQQALSTWVVQQQAKVLQFRRQGPGKagSLVQAVNQTARASNITLTRMQPNNDEVQVWIDEVGFNTLMTWLGSLDTT-GVRVLQVDITEAGAPGNVKVRRLQLGKS
12 UniRef50_P31709 General secretion pathway p... 113 2e-24 1 25.0% 22:177 1:160 ---------------------MNELRQRWQAMSQRERQLMVVCAAVLLLCVVYYAILQPWQEREDLWERTISREQQTVNWMQKQapRGNQAQGDNSQRDVSLPILISQSTKRYGLTVVRLQPQGSQASVTLGQSDFNSLLRWLGELEQKNGVKVISLDVNAVEqpGIVDVTRLMLER-
13 UniRef50_Q3ILM0 Putative general secretion ... 113 3e-24 1 20.0% 23:177 3:157 ----------------------QQLIKHWRSLKEQEQQLIIVASGIFIVFILVMGIFRPLNNAIASAEQSQLKQQELLVWVDESIVKLKAAGNTQVVNSQNISQIVNATRGRYKINISKMQPSNNSLRLTLDSVEFNQLILWLDELVNQHGLRVENLDLSRDDKSGYVRVSRLLLEK-
14 UniRef50_Q1ZIZ1 Type II secretory pathway, ... 110 1e-23 1 26.6% 23:176 3:159 ----------------------EKWRIWWATSNIKERRLVVVIVLFLAFSLCYWGAWKPLSTRLDNSEIQLLRTQKTLSWVQEKASLLLKSGRgaQVPQSSLVEVINRSAKRSGISFTRILNRNDTLEVWIADVEFNNTMDWLTLLKNKYGIEVLNVDINQALKPGYIKINRLVLG--
15 UniRef50_Q21EQ3 General secretion pathway M... 110 2e-23 1 18.7% 22:171 4:155 ---------------------VNEFKEWWGNASSRDQISLVVCSVCVALYILFMGVLSPLYDMRDAQVRSHESAVVTLARVKELAAQIKGSGEGNGRSGgsIVDLVDSSLRSHGLRLSNMQPSgsDVRLRLDEVSFNSLLAWLNEMEVEKGLQVKDMSIAESSNIGMVSVT-------
16 UniRef50_Q2SFC5 Type II secretory pathway, ... 110 2e-23 1 21.5% 14:176 5:173 -------------QQLKKIPAVGKGLTWFYGLSQRDQTALKWMALVVAAFSVYMFVWAPVQDFVESSKNSAEASHESLTWMKENEARARASSRqsISGGQSLLSTVGSSARKFGLELQRFEPRgdKVNVWLDKVSFNQLMLWLGELEKNYGVAVEQITVDKADAPGVVS-SRLSLS--
17 UniRef50_Q15ZB6 General secretion pathway M... 109 4e-23 1 24.8% 22:178 1:159 ---------------------MNTLKQKFSQLTEREQRLVLISAVVVVVGMFYWLVWSPLNQAIERDQKALDSQKSLLSWVQKSANRAIQLRAAKGVsnGSLAQAANQTAANANIPIARMQPQGDELQVWVDQAPFNGVLDWLKSLEE-MGVSILDLDIAEADAPGQVKIRRLKLGKS
18 UniRef50_C4K3F9 Putative uncharacterized pr... 108 6e-23 1 26.8% 25:177 1:157 ------------------------MKQRWHHLSLRERYFLIGGVFCLLTFLSYSLVWQPLQKKILLAQKKLEQHRQLLHQIhaLKEWLNRRHQNAILPDESLSNIVHQSAAQAGMEIIKMQEEEKALRVWIAEVSFKKLVSWLFDLQYRHGIQTAYLDLVETGIPGIVEVQRLEFIR-
19 UniRef50_Q1N4H7 Type II secretory pathway, ... 105 5e-22 1 17.0% 10:174 10:174 ---------SNLKRQLEQSSIYQSVHNWYSQLGTNDQSIVKVLLFVISLVLIYAWIWQPAVDARDAANKSFNKELSFHESLKENAYRFKGGSSSNQPSGGSILSIVSATAKAKKIELRRFEPDgtRLRIWLDKAEFDAVIDWIEILEAEKGILVEQISLDKVS-SGRVNVRAVL----
20 UniRef50_A0YBF1 Type II secretory pathway, ... 104 1e-21 1 17.4% 16:176 5:167 ---------------IKDSDVLQQFSVRYESLENRDRLAIKLLLGFIVTVIIIFGMILPASNYKASSEAYYRNSLETLTWMQGNKPLIDSvrRLVRDSGQSLLGIANKTSKGFNLTFKRYQPVGegLSLWLENESFNNVILWLERLDKRHGISVDEISVDRDEQDGLVSI-RLVLQ--
21 UniRef50_A5ID27 Putative general secretion ... 103 2e-21 1 24.5% 25:175 1:151 ------------------------MKTYLNTLNDREKWMVIVAGVSLFIYGYYLLLYAPLSNQVNQKSTQLIEKTETLEWMKQVRMQKRSAKRKESVDNSQLLTILASQLKNnkFPYQLQQTGSGDVQLTFDEVPFQNFIQWLAKINEVYSINIKQFDVEKTPTPG---VTRLMI---
22 UniRef50_C6XJ56 General secretion pathway M... 103 2e-21 1 22.1% 25:178 2:156 ------------------------IKNWWAAREPREKLLLSICLVLTLTIVLFQFIFGPSVEFRDRASKrlSQASSHSEVVQTLRVYENSPRQVNAVSAGPVQGVVSDSSAVFGIDISRIEpsNGDLTLWIEEIDPQSLYAWLTDLEINHGISVNKASIRMNKDTVTVNANVLV-SRG
23 UniRef50_A4BDW7 General secretion pathway p... 102 4e-21 1 22.3% 22:178 6:161 ---------------------LEPLREKWLSLSRRDQQAARLLGISLLIAIIVFGLIVPLASWRQDLQRELANAQQTLQELTALAPQAMAVTGGATenPSIMNSEIRRQAARYGIEIQRFEPDGELLRVWLDDARYPSVVQWLGGLE-NMGIGHTELALDDRPNPGFVNV-RVTFGVG
24 UniRef50_O32575 W0031 n=14 Tax=Escherichia ... 102 4e-21 1 28.2% 22:177 1:159 ---------------------MNELKKRLQYVSPRERRLLIGCVALLVVVFVYYVLWQPWLIREDKWRTVVTREKNTVEWMKQQVPNIKRREASMPEQGEplSAAVTRTSAAYGVSVTRLQPQGERLAVTLAPVEFNALMQWLTQLERRHRIRTMVFDVAAQGnpGQVTVNRLVLSQ-
25 UniRef50_A1SR65 General secretion pathway M... 102 7e-21 1 25.8% 22:176 2:159 ---------------------VERLNTWWESITEREQQLSLVSVLLILIAIIYWGIWQPLSIGLDNSENQLQRAQQTLSTTQQRATLLVSaqGSAVSENQNVTQIVTISAQQNGITFSRIINRNEQVEVQVSNVEFDRFINWVSVLSSQYSVSVLNADISRADEEGYIKVTRLSLG--
26 UniRef50_P15752 General secretion pathway p... 102 8e-21 1 27.4% 22:178 1:158 ---------------------MHNLLALWQQRTRRERCLLLGMAVVLLIGLVYYTLWQPWQNREAQWRQTLAREQASLQWMRQQTPLIRQLRNQKPPtpEEPSTVIMREAARHGLTIVRLQPQGSRLSLTVQPADFQALMAWLDALGQAGMTTATLAVTAVAQQPGWVTVNTLVLERS
27 UniRef50_C5BM29 General secretion pathway p... 101 1e-20 1 18.7% 22:171 1:153 ---------------------MNELKEWWNKASTRDQLSLAIGGGILLLYLCYMVLLKPVTEMRDNQLHRNMAQAEALERVRELAATWVNRegDSSDNGRSLVDVVNSSLQQNSLRMTGMQPSgnDVRLRLEQVPFDNLLAWLYDIEVSQRLQVKDISVATGSNEGLVSVN-------
28 UniRef50_A3MPL1 General secretion pathway p... 100 2e-20 1 18.6% 19:174 11:169 ------------------TEFNEALSQFWEARTAREKLLLGWGGAVLALAIAYSVLWSPAQEGRARIQRELPTMRHELAEMTAQANEARTLAGAaaPTGVALKDALAASLSDHGLAAAAPQVVGGGVQIQLKNASFPAWTQWLDDVRRQFKAQVVEAHVSALKEDGQVDLTAVL----
29 UniRef50_B8GU53 General secretion pathway M... 100 3e-20 1 25.0% 25:176 1:157 ------------------------MKAWWEGLNQRDRRILMVGGALLCLLLPYMLIWQPLHDRAERLERTLVAQRADVSWmaAQLRATAATGRTPTPAGQSLLGMIDRTVREGQltVRRVQPEgnTVRVWLEDAPFDELMTWLGTLETRHGIRATSLVVDRQATPGRVNA-RLTLE--
30 UniRef50_D1RFN4 Type II secretory pathway p... 100 3e-20 1 21.2% 25:175 1:151 ------------------------MKSYLSTLNEREKWMLIGTGLCLILYIYYLFLYTPLNNRVNQKSTQLVDKINTLQWMKKIKQQGRTTQTKQVVSNSQLLTALATQLKnlKFPYQLQQTGSGDIQLTFDAVAFNLFIAWLEKINQGYAITVKQFEADRTKTPG---ITRLMI---
31 UniRef50_A1WZN8 General secretion pathway M... 99 7e-20 1 24.4% 15:178 3:173 --------------REALQQLRAEAERFWSARNPRERWLLGSGGLLVLVVVPYVAVWEPLTERRDQLQAQVAEQRQDLAWMRSAAEEIHAHDGdpVTDERSLLSLVDRAAREAGiqLSRVQPDGDglRVWMDRVPFDELMNWLDGLQRAAGVEVDALTVERTQEDGLVNV-RLTLEVG
32 UniRef50_A8AIM9 Putative uncharacterized pr... 98 1e-19 1 14.3% 18:171 1:152 -----------------MKERIAQLKARYQNYSDRERGLITLCAAAMCCAVIYYGGIIPLDHMIQNSQSTLMRQKETLRWMRDEID--KNHLQAKVLKTNNPRTVIEESAKEIHLALSDIRQDERSLSFVVEQVNIYELKNWLREVNVTSGVQLQKMDLRPVDRQSDVKAN-------
33 UniRef50_D0XKE5 General secretion pathway M... 98 1e-19 1 18.5% 11:172 3:159 ----------APVLPNRASPALDAATAWYAGRSRREQVLLAVLGGFLTVAVLWLGILQPLLDARATAIGRIAAYETVMVRVRTAGP----VGATAAGLSGPLETAIPAQAATFGIIPASVTPDGDAATVTVTEARYDSVVPWLAGLEA-SGATLSSVRIDRGSQPGVVNVSV------
34 UniRef50_B3PEM1 General secretion pathway p... 98 2e-19 1 21.3% 22:171 1:153 ---------------------MNQLFAFLNRYQRREQIALLALGIAVVIFLLWILILAPLQKKREQLQTANTAATQTLGKVRIMAAQIQQArgGQARSGENISGLIDSSLRGNGLTMSGFQpvAGEVRVRLDRAAYEPLMQWLYELEFKHGVSVRDLSLAATNDPGLVTVN-------
35 UniRef50_A0YG42 Type II secretory pathway, ... 97 3e-19 1 20.3% 25:172 1:153 ------------------------MQHWFYSLKRQEQIVLLFGIVVVFSYLLYVVVLRPLSAAVERLEQKNEVASRSLNVVEALSKEYQSLKKKSGSEaqNLTRLIDTTVKNNTLTMTRFQpsSGEVQVRFENAVFDNILSGLHELEVGNGIVIKDLSVTNGSATGLVNVSV------
36 UniRef50_C4L989 General secretion pathway M... 97 3e-19 1 30.5% 25:178 1:157 ------------------------MKQWWQDRTTRERRIVLAAALVLLSIILYWNVWSPLQQHLQQQRGQVQQLQQQLSWMQQQAPLVRQLKQQSASpsGDIASTLSNSSQGYQIVLKRIQPQGTNALVEMDTTSFEQLVSWLNMLEQQYGITPQQIDLQPAEVPGKAQVRRLLLGRN
37 UniRef50_A3SDU2 General secretion pathway p... 95 1e-18 1 25.7% 27:174 2:147 --------------------------KAFAALNPRERRLVGIVLPLAIVVVGYQFLWAPLHRAQAEARADIQAFRLVQDTAALASVDTIVSLQPLNETP--LATRITTSASAANLTLRRIEPENDSIRVTLDDTPFATILLWLSDLEEQHDVRVEALEVDRRPAPGRVSARLLL----
38 UniRef50_Q0A613 General secretion pathway M... 94 2e-18 1 27.9% 23:176 3:161 ----------------------ERLLAHWQGLEPRERRILLAGALVLAVLLPWGGIWLPLSDRAETLRGEVAEARAQQAWMAAAAERVRQAGGATAVPGesLLGRVDRSAGDYGlrLERLQPDGdrVRVWLERADFDQMLYWLDALAET-GVRVHALSLEPLDAPGRVNA-RLTLE--
39 UniRef50_A3WP21 Type II secretory pathway, ... 94 3e-18 1 17.7% 13:176 8:173 ------------LQKIAQTPVVQSAQQRWAQLAVREQNLVKGLGAVIIVAIIYFAIWQPTYSAQQLAERRLEGQQQQLLWLREQVARYQSLSATQAQssGSLSQRVNEAAASNKIQIARMQPQNNGLIVSVDETSYQQAMSWLYALEQTYQLQVTTLDLARLDELGKVRVRQVLVT--
40 UniRef50_Q3BXL7 Type II secretion system pr... 93 5e-18 1 21.1% 18:169 1:150 -----------------MKTSVQRGTYWWQTRAPRERRMLGVMCAALAAFVGWYALYMPLRHWHDRAWARYADAAQL---VLDASAQAASTRHTAAPGPAALAKIIASSARDAGVNITSQQRsaGGVEVQIEAVSAATLFGWLKRLRQAHGLAPTQLHVAREQGQLRVR---------
41 UniRef50_B7UZ45 Probable type II secretion ... 92 7e-18 1 20.0% 16:165 16:165 ---------------QRWSPLLLRLQAYWRQLAPRERKILAGGGLALCLALTWQVFIDPPLARIEHWQAELPRLRAQAAAVDGVLREVEALRGP-TLSGTADAEAIRRSLRDQGLdfQLDAPQPGQWQLDFASVSGEALLRWLARSPAALRLSVSEAQVTRLDAP-------------
42 UniRef50_Q0VPY0 General secretion pathway p... 92 1e-17 1 19.1% 15:171 8:167 --------------KKLAAQRREQAVQWYESREPREQHILKILAVVAFVVLLYWLLWAPSVAARDQAKKQFMVNQQTLQWIQDNREAVIAARrsSAQPNGNWTGNVSRSADQFGLTLKGFSPDGNrvRIQMENQATSQTVLWLQSL-QQSGIQISNLEMTPGEKSGTATVR-------
43 UniRef50_Q1NDR5 Putative uncharacterized pr... 90 3e-17 1 21.0% 22:178 1:158 ---------------------MDRLGLYWAERSPRERWMLGVMFALLAIVILWFGIAVPLDRAQRDARDRLVEATERNAAIRATVAQLKALPRAPAnsTVPLDQFVGQSAGEAGLTLERAQAQgdRMDIAIASVRPIALFSWLSTLE-GQGVRVVTMSARPSPTAGSISVQA-VLERG
44 UniRef50_B3R7X0 GENERAL SECRETORY PATHWAY M... 90 3e-17 1 18.9% 8:171 28:194 -------TRLARLRPSVPQAWRERFDAFWSARNPREQAILAGGAAVLALVLGYLLLWEPAADGRDRAARNLPQLRADLAEMETLAQEARGLKATPAPsgDELTQALQESLGQYGLKATRLAAAAdsVQVQLDKVPFGAVSTWLQDVRQQQRMKVIDARVVYVGATALVNVT-------
45 UniRef50_A1U0C6 General secretion pathway M... 89 5e-17 1 19.6% 13:175 2:175 ------------WSRIKDQPAVGKLIARYDQLPTRDRQALTALGIALLLALIYLLIWQPVTQFHDRAASSRENAAELLAWMRANETTIQRLgaDKPEDGRALMALVTRSAGEAGLSLQRFEPSGEgiRVWLENAAYADVAAWLERLHSNHGVVIDQAALDRGNGPGQVSV-RLTL---
46 UniRef50_B7RST8 General secretion pathway p... 89 5e-17 1 22.3% 25:172 1:151 ------------------------MKQWFTGLTQREQLSLLIMGLAVALYLAFVIVIAPLSQARDRMVVQNRGVAESLQRVEVLVSQILHLrgNGSSTNRNLASLVNRSTSSYQLQVNRLQPNsgELQVRLENAVFDDLIAWLYQVEYKEGLRVLETSITQAGTVGRVNATV------
47 UniRef50_D2TMG9 Putative T2SS protein M n=1... 89 7e-17 1 14.8% 23:164 3:142 ----------------------KRIREWLQQKNPTEQRIVIALFILCVATIYGCGLWLPLNHTVDALQTRCNKLRQDMAWLEKQAQARGVLPQRTPEEP--VASLLKKEAEQAGFSVTLTQNSADGVEISANDISQQAFTAWLTRLQSRHGLYVETLEFHASPA--------------
48 UniRef50_A4A5K6 General secretion pathway p... 89 9e-17 1 20.4% 25:171 1:152 ------------------------MKDWFERYTLREQLALLAMALVVTLYLLGVFVIQPLGQARADLAARNTATAEALLRVDAMATEIRALEDTEGSTRgnLSASLNQSAGRYALRVSRLQPNsgSVQLRFESAPLDALLRWIHELETTQGLRVDDLSLSQTSTAGTVSAT-------
49 UniRef50_P36678 Putative general secretion ... 86 4e-16 1 14.5% 25:176 2:150 ------------------------IKSWWAEKSTSEKQIVAALAVLSLGVFCWLGVIKPIDTYIAEHQSHAQKIKKDIKWMQDQASTHGLLGHPALTQP--IKNILLEEAKRENLAITLENGPDNTLTIHPVTAPLENVSRWLTTAQVTYGIVIEDLQFTLAGNE-EITLRHLSFR--
50 UniRef50_A4VFT9 General secretion pathway p... 86 5e-16 1 19.6% 10:172 1:164 ---------MNLKQQLAVRLADSPLWQRWQRLAPRERTSLSLLGAFLLAVLFYLWLWLPAQRQAAEARDYYQAQRELHAYMEQNTELARQMERSNQVepEQLQGVITESAQQGNLSIESFDNGSDglQVSLPGASYALLLRWFDTL-QGQGVSVTEVSLERAGE-GLVNARV------
51 UniRef50_B5JVC5 General secretion pathway p... 86 6e-16 1 21.6% 27:165 2:145 --------------------------EWWHRYSQREQRTLLAGGAVLAVFLIYMLLLEPLVDFHQQGKADLETHRELHQWMAQAVAEYRSIGGSQSApsGSVAVAVENALKQSGlkATRIAPKGqaVSVSYDSVAFDRLMHTLDKLTLDQGLQLAQFQASAVGDE-------------
52 UniRef50_C7R8F1 General secretion pathway M... 85 7e-16 1 22.0% 22:171 1:153 ---------------------MSAIKTLYSGLQKREQNMVLALGIAMTILLVFLLVVLPLKSYFDNLNDDLSYYESQMVTVQKQVAAIKSAgaKANNTNVSLNQLVNQSAKSFGLSFSRIeeRNKEIQLRLDDVEFDQLLRWISLLEQERGLVVDTLRVSKKDTVGKVDAS-------
53 UniRef50_A3UEX1 Putative uncharacterized pr... 85 9e-16 1 12.8% 17:165 2:153 ----------------SQTTLFTPLIKAFQARTAREQALLAGLAVLVVLTIAWFGVLAPAMSWRADAARRYANAAEGYESILVQASEYRALSAQaaDDREPLRTLADRTARERGLAISRVQpeDGRLGVWMEQADADSLMGWLSLLSREHGVNAERVSLDREGET-------------
54 UniRef50_Q31J18 Type II secretion pathway p... 85 1e-15 1 20.6% 19:173 4:162 ------------------DNLKQTALQIWKGFSQRDQRAIMILGGVLLCAVLYFLIWLPSEHAKQQAQQKLALSQQKWDWLNEQLPKVAqlPASTLKTTEGLMQFIQAQLRQLNltIERIETQGHKVVVEFKEVNAPRLFRWLSQ-QEQQGLIAYSADLKPL-QPGIVTAKVI-----
55 UniRef50_Q0ASQ4 General secretion pathway M... 83 3e-15 1 18.6% 18:178 1:163 -----------------MMTRFAPVLAWWDGLSSREQVMMAVLGALAMILLVSLLIIQPLLGAHDRARDSYAASMRLYRAVEADADTVqaAAPASTAPAQSLRAVAGSMALRHDIALARMVpeDGRLTVNIDRAETAAILAWLVDLDRRYGIRAQASTLDR-DADGFVSAS-FVLSRG
56 UniRef50_Q0C118 General secretion pathway p... 83 4e-15 1 14.4% 25:170 1:153 ------------------------MTGWWNTRTPREKMLLAIAGFILAVAVIWQLVLNPAIHTLERAKRSHEQSAQTLArmQQGETILPYATAPSTQDTAALLSEAERMAREGNLLLSGSEpsPSSFRVKLSAVSGPAFFQWVEQVETGLGVSVSAASLTQ-NADGSMDA--------
57 UniRef50_B7RHZ7 Putative uncharacterized pr... 82 6e-15 1 22.0% 27:176 2:149 --------------------------NAFNRLSLRERILVLIALPLVILFAGYRFGWVPLSEARTAARVEIQGYQTLIEAAENQGNQPVEVATVAVVT-TPLATRITDSAARAQVLVRRLEPEGALVRVTLDDAPYDAVIKWIAAMETDAEIALVAIEMDRRTAPGIVAA-RLTLE--
58 UniRef50_A0Z781 Putative uncharacterized pr... 81 1e-14 1 23.1% 25:171 2:150 ------------------------LGDWFNARPRREQLYLLSMILAVGVWVVVQVIILPASAARQQMEINNQRASEVLTRVDAKATRLVALraAQSSDRSSLTAAISRISKLEGLVVRRLQPNsgEVQVRFEAINYDALVKWLYRLEVTEGLLVIDVAIVRSSGAGGVNAT-------
59 UniRef50_Q1IB25 Putative type II secretion ... 81 2e-14 1 14.4% 15:167 4:147 --------------KARINGLRGQARQRWQALAPRERRAVALAGAVLGSFFCWQVLVAPALTRIEHWNTETPKLRSQAQALDALLGQRSA----------DLAGALAQSLDEAGLRasQLDAEGDGWHLAWRQAPAEPAMAWLQRIPPRLGLTIGQLSLRRDPGAGT-----------
60 UniRef50_Q2Y7T4 General secretion pathway M... 80 2e-14 1 20.0% 22:171 2:154 ---------------------RKQLRKAWESRSPRERRVITILGMIL-SAGLYLGLVSSADRARTRLRSNLPQLRVQAEEFEQQAAEYERIKVTPSPPpgDLHALAQTQADILGLSHALNGIddDQVQVTFKAVPFADWLKWTVAMQLQ-RVRFEKGRIEALPEPGIVTVT-------
61 UniRef50_Q5QY94 Type II secretory pathway, ... 78 1e-13 1 24.2% 16:176 6:169 ---------------RQLMPYLDLGKQRWQQFNQREQSLLAVLAGVLFIAFLYFVIWQPSSQAVANAERQLAAQQQQYQWVQQAIARYKKlsSEQQSASGSVSQRINRAAAAQDIQIARLQPQGQEYLLSVDEVAFSDLLSFLAELEQRQGLSLKAVDIAKLNTPGQVRLRKLLVS--
62 UniRef50_C3KC63 Putative general secretory ... 77 2e-13 1 17.1% 8:165 18:170 -------HSLTLWRGQ-WQHFNARTRGVWRGLSRREKRMVAGTALLLVGLLSWLVLIQPALKKIEYWQAETPKLRAQTEALERLLREV-----PTPTAGQPLEPALRQSLDARGLvyYQLTPVETGWQLTFETAPADAVIGWLVSNPRQFSLEVVEARLQRAGEA-------------
63 UniRef50_Q2G4Y9 Putative uncharacterized pr... 77 3e-13 1 19.7% 22:178 2:157 ---------------------RSGLNVWYGGLTARERGLVSVAGGLVASIVLVYGIVLPVGTALDDAADRHRNATERAGRIEAQIAALKAApgKTAVLAGPVEQIAGASAQEAGFVVQSNQRRGSDMAViiPTARPSAALAWLDGLMAQ-GLAVEQLTMTPAP-DGSVSVN-VTLRRS
64 UniRef50_Q48JN4 General secretion pathway p... 77 3e-13 1 17.0% 9:167 5:161 --------YVDRWRRLS-----GRVRVARAGLSIRETRLLSIGALVLCCLVTWLLMVQPALKKITYWQAQNPVLSAQAETLETLLKQVRVPQR--RTGPQDLQPALQRSLEAFGlsYCQLEQDGerWQLAFDHAPADAVIGWLLEQPQLFSLHIKDASLQRAGEDAQ-----------
65 UniRef50_D0KWL7 General secretion pathway M... 76 5e-13 1 17.0% 18:170 1:161 -----------------MMKAPVWFSSFWQQRNQSERRTLTLAAIALVALVGYQFVWSPMQQAVQRAHDRLAQAEQLAAFTAQAKKALMQAGPKSAQPSADSPMlvEQAARTVGIEQQLVQRqdDRVQLKFAAVPFDLLLRWLAQ-ANDAGLSVQSANITpsDAAGLVDA--------
66 UniRef50_Q8GBD7 Yts1M protein n=2 Tax=Yersi... 76 6e-13 1 18.6% 22:177 1:158 ---------------------MTKIKQRWQNYSKREQLIFSLGGLVLLGLIVSQGIVAPLENYQHQSTQNLHSAQRDFAALLQQQERISRLQAQRPPqaLSADRALHESAHQKNMTITLLEANANRAVVAPLTLPFSQLLSWLEQLEAQYGLQASQLKLVavDNLSRVHITTLVLQR-
67 UniRef50_B8L5U1 General secretion pathway p... 75 1e-12 1 18.0% 22:171 12:160 ---------------------LAGLQQRWQRLPPRDRLMLGVMMGALLVAGLWSFWLEPLLKQRTHWQAELPRLQAQANALAPlaRERQQQARDQRPTLAGLRERIRSAGLAEGLHI---EARDGRWHLRVQGVPADALWNWLLPVLADPAIELQQLQLTRTGDANMPAAR-------
68 UniRef50_C6P582 General secretion pathway M... 75 1e-12 1 19.5% 18:171 1:158 -----------------MKALLARLKArwDVLGATEQKTVIRGAWILLPLLMYGLLWQPAHQALPKLQTALPQLRAQAAQMQSLAGQVQSLRQQAQpdSDALKIAVEKAASEANLPLQIVPGEPNSVRISADSIAFAQWLQWQRSLEQTHHIRVSSAMLVATTETGMVKVQ-------
69 UniRef50_B8KQL9 Putative uncharacterized pr... 74 2e-12 1 14.3% 25:171 1:149 ------------------------MKTWFRQLPQRDQIALLLLAGALSLWLVYQALLMPAKTQRERLLATNDAAAQLLGRVDTKVSQLMYLrqGGSRRSQNITATINSTTRALGIAVQRMQPNsgEVQIRMEDVDYDLLVRWLHRIEVVEGLLIVEASIAQSGRSGSVNAS-------
70 UniRef50_A1TKM9 Putative uncharacterized pr... 74 2e-12 1 13.1% 21:165 16:160 --------------------RTEVLRARWKTLAPREQSLVLAAGTVVAVALLWWVALAPALRTLREAPAQHAALDAQLQRMQALQSEALQLQAAPAAPAGDASQVLRTSLAQRLGSQAQISILGDRATVTLKAAPADGVAEWLSQARSNARAVPVEARLARSTAA-------------
71 UniRef50_Q8KTJ4 GspM (Fragment) n=1 Tax=Bur... 74 2e-12 1 17.3% 42:174 1:136 -----------------------------------------WGGAVLAVLIGYSVLWSPAQEGRARIQKKLPTLPHELANMTAQAHQGKSLPPPaaPTALALKNALTGSLSDHGFKGAQGQGVGGGVQVQMKNVSFPAWTQWLDDARRQFKGQVGEAHATALKDDGQVDLTAVM----
72 UniRef50_A5V9H7 General secretion pathway M... 74 3e-12 1 19.2% 20:170 15:162 -------------------PARQKAIGLWQARSRREQWLLGGLAAMVALYVLVAMVILPVQRARAQALSDIRTYESLSARLRSAGPLGQAPAQPQA--GGSPAAVLSASAARFGMVPV-VNEGGEGIRVTVADAPYESLLRWIAEVEQTSRLRVVRLRLDRRPSSGFVSA--------
73 UniRef50_C6HW27 Putative uncharacterized pr... 73 3e-12 1 16.1% 1:161 1:182 MIRGEIFRESNQKVQAHVDRLLRPLRVAHERLTPREKRLVRILLSLVGGIVLWQGVTLVFWDPYQAREAELADLRSETLKVATLAREIESSRaaREERGFSLISTLEEEADKAHirITRMTPRtaMVSLEIDSVDLPHALVFLARIQRshFIRVTRLSMKR-----------------
74 UniRef50_D0LLX2 Putative uncharacterized pr... 73 4e-12 1 13.2% 18:161 1:158 -----------------MATSMERLRDRWEQISPREQRMILVLGITFVVVVLALlgISGGLGAIEERNEQVRTALRSLGDYREHLAKGGGTPgnLPDEPVKLQSYLEGVATEVGITIPGFKPQTGSarIEVNGLSLSQLTAFLERVESKSpvMVEQLDIKR-----------------
75 UniRef50_B1Y327 General secretion pathway M... 73 5e-12 1 18.6% 11:177 4:168 ----------APTLPPALQQARAQLAQRWQALAPRERTGASLAIAALTLLLVWSVAIQPALRTLRTVPAQRAELDAQLARMQALAQEARELRALPPVAPEQSENALRGATTRLG-AGARLNLSGDRATVTLNAVDPAALTAWLAEVRSAARARVVELQLNRSGA-GYSGTVVLTLGR-
76 UniRef50_A3YCB4 General secretion pathway p... 72 8e-12 1 19.9% 15:175 7:170 --------------QIRSSSLLLPLLQKYQALSKREQKLVACLAFVLFIYLLYSLLWVPIHQQKEVAQKRVDANLKSYYLLVENAPLLTKSLGDSGvsGQALQALVSRTMRKQKLVAQRMNLDGdrLQVWVENTSYSDINKWMTILAKEK-VSIYSVQFA-SRELGVVD-MRLTL---
77 UniRef50_Q2BKX2 MSHA biogenesis protein Msh... 72 8e-12 1 13.6% 18:157 1:133 -----------------MSKRFQNWSAKWQGFSPRERILLLFTAVVAPVVLIFIFLLEPALITLQKTPAKIETLQTEINS---QQRVLDLLRGQQVKDPN-----VAARAELKKLRTQLSDVNNEIRRAATNLVTPDQMLSMLHslADDQGIKLVSA---------------------
78 UniRef50_Q15ZI8 MSHA biogenesis protein Msh... 72 1e-11 1 13.3% 16:158 3:138 ---------------QTLKERYNTLFAQFLAITQREQILILLSGVVVIGMVGYLLFIEPVNETVTRDEQNIASMRNQVRSVEAQIE--VSEHAFSNDPNEQLV------ASLNKLKQRSLDLDTDLQQETVNLVPPKQMPLLLEklAESQGVTLISMQ--------------------
79 UniRef50_C6CIM7 Putative uncharacterized pr... 71 1e-11 1 17.5% 22:175 1:146 ---------------------MNAVSYAWRAFTRAQRRWLAAMGAIVI-------LLSALLVHVGEKSAQLHQASVWVAQQQDFTVWL-AARPDKKTLALPLQEALRRSAPPAALAAVFQYHPREAVLASPAAVGFNALFLWLSDLQQQYGISVVQLDVVPANEPGDIRLMHVVL---
80 UniRef50_A3VSL0 Putative uncharacterized pr... 70 3e-11 1 21.1% 25:176 1:148 ------------------------MTEFWYARSVREQRIILAGAGALLLLIFVLLVVQPL---IDYRRTAIADHQRAMDTYLAVTRAVSRASAGPVREPSVLRSTIDRVARERQIVLTRTAIDEDAVVVSTGGVTTATLMNWLDTLRDEHHIAVRDAQIRPASAGNGVTA-RLTLG--
81 UniRef50_C8R0C1 General secretion pathway M... 70 3e-11 1 21.9% 18:177 4:174 -----------------LKEIRAGLEARLEGlpPRQRPLLFIGLGLLVPLLVWLLLLAPLGSSRDSLQRDIGAREQELAWMREAAQEVQrtAGNGARPGGSPLAAIDSSAREFGlaMQRVEpdGGEVRVWLEDAVFDDLLRWLDRLGRGHGIEAVEVVVerGGRAARVNA-RLTLIR-
82 UniRef50_B8GXS2 Type II secretion pathway p... 70 4e-11 1 19.0% 18:164 1:144 -----------------MNGRLEAARLWWTGRTGREQVLLAVMVAALVVVIGWYGVATPLWSAAKTAQVRVDKAATQLATLRGLAAGASRATAGGAAP----QAVVEAAASRVGLPIArrQDANGRFTIWIAAIDSKILLPWTAGLEREGAVKVTDFTASRLDN--------------
83 UniRef50_A8ZWZ2 Putative uncharacterized pr... 69 6e-11 1 15.4% 18:166 2:169 -----------------IQPLMSRAATFFRGLTPRERYAVCIGVAAVLLLFFWKGVAAPLSDKRETLVVQLASRQNDLKQMITLQQEHERMqqSGRGADFTLFSFLDRLAGRAGisVSGQNSELSVVEMKLEGVDLQGLVSYLHMIEtdAMVFVTRLSIAAQEKGG------------
84 UniRef50_UPI0001979A79 hypothetical protein HcinC1... 69 7e-11 1 17.2% 19:163 3:174 ------------------SKILNPITQFLSTKTKREKILLFIAIMALCVFIMMEFIYLPLLQtlDSMQSAKAQHQQQTNEVQNLQEEIFSLQQSLSHtpFTLIPSLINFAKNENLTLNAFHPHPTLNALVIEGseFWQILNLLSFLENLHFVSLESLELSSQE---------------
85 UniRef50_Q1D9F1 Putative uncharacterized pr... 69 9e-11 1 14.2% 16:170 2:174 ---------------AKLQEVFAPVQTWFERLSDRERRMVSIAgvLFAVVMTFTNSASGYRKRTEEKLTKLQEVNTLAASFREAQANRQSVEQQLRSSNVQLISYIEDKATLAGLQVPNMTPKGeaVELTFTDVDLRKLTDFLQTVESGPgvKVKLLRIEPRPASDTLTA--------
86 UniRef50_A3W189 Putative uncharacterized pr... 69 1e-10 1 15.0% 18:170 1:163 -----------------MSALMDRLTGFLLGLSRRERWLVALLGLIALPLAAVYGIALPLADSRETARAAVAEARATELWVADQAVQFATLARDAGNGPKVARAtiEASLRDAGLrsQLANAADGGITLRFDAVRFTQLAEWLTSQNDIWGYDLAGFTFERGARTDVVAA--------
87 UniRef50_C8PZS1 Putative uncharacterized pr... 68 1e-10 1 16.4% 16:161 9:148 ---------------QSLQKLTTPLGHAFQNLSRRDQIALLILAMFLLFFVVGVGGWT-LHSKANLAQKKYDDTMVDVFWLRSQAGNINPNQTQQVNQADAIKQILSQS----GIVNAQVVENGNTIQVAFSHAQASVITNIFNQFE-QQGIRIQQLQINQ-----------------
88 UniRef50_Q1GWC5 Putative uncharacterized pr... 67 2e-10 1 18.8% 23:171 3:152 ----------------------ERLKYWWAGLSGRERWLVGIAAVLALGVLGWGLG-RPAVAAFIDLENRHRAAIEREGRVAAKVALLGARPqaASADAGAIDQFLQQSAGEIGLTLDRNEARgnRAAIAIATAKAPVLTDWLASLEAQ-GFVIDQLTITPA-ADGTVGMT-------
89 UniRef50_Q1YQU6 Putative uncharacterized pr... 67 4e-10 1 20.6% 25:165 10:152 ------------------------ISAWLSQRQPRERIIVVVGAGIVFVVAVYLALL-PSLERSTELQERHRILQADLHWLSEQSDSVSRLSNskTIKPGAAKDVINRLVRRNQIKLVKIAEQAQgyALSLESINANRLLQFAHQLACQ-GLKTNLLDVSRSDAT-------------
90 UniRef50_A5F8T2 MSHA biogenesis protein Msh... 66 4e-10 1 11.7% 18:171 1:145 -----------------MKSGWQNFESRFSALSQREKVLITLCGSVLIVMMLLLGLIEPALK---QGQARQLQMQTLTSSNLQLQGEIMALQAQLAKNPDQELDV-----ELSQLTLQSQEISELLAAKMTSMVAPSEMPNLLESV-LKQGQQLKLVSLESLPAEPIVRAT-------
91 UniRef50_A6GLQ0 Probable type II secretion ... 66 4e-10 1 14.2% 17:164 2:154 ----------------KPNDLLNKAQAQLDQLNSRERKLVTYGGALAAVLIAWFVLIEPALLTIQQGPANQAALVDKAGQVMRAAQDLEALRGARsvPESDLQARLQQLLEEQGVsaTLVRTEEGDIRVEFNNVSASGFLAWMARAEAISSISLNLAEVEKVEA--------------
92 UniRef50_B9TJM6 Putative uncharacterized pr... 66 5e-10 1 19.7% 62:178 2:118 -------------------------------------------------------------DGAAQLHKELPQLHQQAAEMQVMAREAQALQGQNTIAPSPmrEMLNAGLSARGLTPQSLNVTGEYAKLQFNGAQYAGIVAWLDAIRTESRINVVDASFTAQDAPGVVNGT-LTLRQG
93 UniRef50_B0TEF5 Putative uncharacterized pr... 65 9e-10 1 14.9% 27:160 35:198 --------------------------NWWMARTKRERVLLSLFGAAVAGAGLYLLVLEGQLDQFSTLSTELPVSKQQLESAKRRIQNRQGLEqpAALSSGSMAVLIGEAAKASKVTIKYFVPQPKlaEIPVDIVafDALVDFSSRLEtrGGALVRNFAIT------------------
94 UniRef50_Q7MHC2 MSHA biogenesis protein Msh... 65 9e-10 1 11.0% 18:163 1:139 -----------------MKQQWNAWNDKFLALSGREKWLITLCGLVVIVLLLFTLVIEPAWKQLAAKKEQLSSTIQLNQKLQGDILVIQAKLNKDPN-------------REIDIEMKSLLARSQELGMQLSEvsPSQMAELLEtlDKSSGVKLISLESLRAE---------------
95 UniRef50_A1WTW3 MSHA biogenesis protein Msh... 64 2e-09 1 19.7% 18:169 3:147 -----------------IRRSLQQLNDALNARTPRERVLMVIAGLGVIGAGWYYLLFEPMQQRSADAQQRIESAEQQIRDLRTQR---ESLEAELGDDPEADVRAELDALRDELLALER--DVGERVPEFIEPERMRQVLR--AVLAEHQGARLVRLERLPAQEVAGVE---------
96 UniRef50_Q3AED7 Putative uncharacterized pr... 62 6e-09 1 13.1% 28:172 3:170 ---------------------------FWEKLAPRERILVGIALGLTVFYLLYYYAIMPNWQKYQELKTELNTVNAEWERLqqLEKELKNIRadFNVEDGAGFTKLLASAKEKNIRLLEFKPGSVvvEIKVQGY-YPQVLEYVESLENFPDleIKNLTI--SSVPGDVRGNV------
97 UniRef50_B8FE39 Putative uncharacterized pr... 62 7e-09 1 14.8% 30:171 2:166 -----------------------------NRLGNREKLILAAGIFVAFAILVHAFIITPALEGSRKRQAELRKMESNLVSIMELAEEYKKAKMNTNGddFSLDNYLGQLARQAGvsSKKPIANSDFVqiKLDDVTTEELLNYLHKIETSPnlSVRRITVTRSQREdgVSAT-------
98 UniRef50_B2A7F6 Putative uncharacterized pr... 62 8e-09 1 17.0% 18:105 1:88 -----------------MDEKNKGLINKLSSLSKRERLLLMIAGILVVFVSFWQFIFIPFENRRSELEKNIDHTQQNINHLQGKLSEWADFEEGMTDPKQQIGEL-------------------------------------------------------------------------
99 UniRef50_D0I544 MSHA biogenesis protein Msh... 61 2e-08 1 14.7% 18:119 1:103 -----------------MSPLLFRVKGAFEALSSREQWMIAIAGWIAILGLGVAVFIEPQGNALAQLDAQIMQSEHTTQDLQAlrLKQEKLQSSPNTELEAELERLNQTLSSLDSEIAR-----------------------------------------------------------
100 UniRef50_P25061 General secretion pathway p... 61 2e-08 1 22.9% 15:171 10:168 --------------RLRAQAETSQLAIRWRGLPARDRLALLWLGAFLLLVVLYLALWRPAERHLQSARQYFTEQRALHAYIQQQAPNVRQADAAAPqdPAALQGMVTASAAQAGLSVERLDNEGEgvQVALQPAPFAKLLPWLEQLN-GQGVQVAEAGLDR-QVDGRVSAR-------
101 UniRef50_B5FGN4 Msha biogenesis protein msh... 60 3e-08 1 12.8% 22:146 4:120 ---------------------WNQVKEKFGALSQREKVLITLVGWVAVIFISLSLFIEPKIEQYHQSQQKVARITNSISSLKQQiaEFRLKKDPNVEINKQYQQLMIESQDLADLLFSRVA----------SLVSPSQMASLLEKV--------------------------------
102 UniRef50_B8D2D7 Putative uncharacterized pr... 60 3e-08 1 16.0% 29:147 2:138 ----------------------------WHNLSDREKKLIIFGLIAVICMVYWFYGEQPTTRTIDELESDLQQLRRELMIARVQSKKVKVLKKKYDkdPEEFYETIEEMGKQANvtVQSGQEDERGVNLGVDG-NYEDILNFLSGMR-------------------------------
103 UniRef50_Q12DW5 Putative uncharacterized pr... 60 4e-08 1 11.7% 17:161 2:145 ----------------KIADALAPLQARWHALGQREQTLLRSVALLVGLALLWWGLMAPPLRTLRQAEAQQRSLDAQWQKMQGLRAQAQALQSQPRISRDDALRALQASVKLLG-ASAQLSVVGDRATVTLRNTPADALAQWLAQARANAGAIPDEARLVR-----------------
104 UniRef50_Q47HN4 Putative uncharacterized pr... 60 5e-08 1 15.7% 18:170 4:150 -----------------MRQTWFRLNKRYSSLAKRERQLVAVALILGPLLIGNALFVDPLRARLNGTENTIATESASAAQLQAEAAN---LQQQLAIDPDA-----GRKAELAALSGERDKLDEQLRQLGSALVRPEEMNALLERLLARhgLRLLSltLAPQSALGRVDV--------
105 UniRef50_C6N6C3 Putative MSHA biogenesis pr... 59 5e-08 1 16.6% 19:163 8:145 ------------------AKQLYQLKQKITHLSERDKVLLLFITVIILFTFWFLVIWEPQTNSINELNQKTEKVQGQIDAL-TQKKMIISILISNPNTAGIIknELTTKLAKLNKEITRYNER------YISSRNLAKLLH--DMLKQTLGVTIDDFSTVPPP---------------
106 UniRef50_Q4KD21 Probable type II secretion ... 59 8e-08 1 18.3% 15:156 10:154 --------------RARWSRLRAQALGHWNGLALREKRLLGATALGLLGLLLWLLLIQPPLKKIDYWQAETPKLRSQAEALEVLLHEVAA--GSRNAPGESLEQALRQALDAAGLQGRYqqAGPESWRLTFEQAPADAVVGWLLGAPRQFSLQVVE----------------------
107 UniRef50_B4WDR0 Putative uncharacterized pr... 59 9e-08 1 18.2% 18:149 1:130 -----------------MNGLMSQAAAWWDGRTLREQRMLTVMGLAIAAVLVWLLIVRPAWAWRADAAEARAVAEADLALVQT--ATGRMARTDAASSDVDVAAVVAEVGSITGVTPVMGMSPDGGLGFNLTNVSSTAAFGWLAALHDR-----------------------------
108 UniRef50_A3ERG7 Putative uncharacterized pr... 57 3e-07 1 15.6% 15:161 9:176 --------------RSHANRHLLPIKLRWEQLSRREKRLLSVLGTILALYLLQvfLMTPYQQYRDelRSDIFQALALSREIRQSQEKIRERSRTLAEDRgsLISYLEQEADRTHitPRALPPDGnlVSIRIEKVDLPHILVFLARLErrHLIRITRITLER-----------------
109 UniRef50_Q2KZN1 General secretion pathway p... 56 4e-07 1 20.5% 13:178 8:185 ------------WLKLSqaPQLHTLRARHAALSLRERRLLLAVSAILAAAVIFLGFIEPPLAKLARLRTDLPSLRIQAAAVDDLAARASALSRRAQVRAELPtsLIHAGLPADHWTLTREDAV---YVLTLNDVPAQRLLDWLETSARDWGLLARQAELARapLPGLVNAsrLALTQG
110 UniRef50_A6V156 General secretion pathway p... 56 5e-07 1 18.2% 18:165 1:144 -----------------MPRIPSALHARWLRLPTRERRALLGLAAFLGLSLAWVLLWQPQRQALLDAERHYQDELRLHADLQRL---PGDTGGGPRIDATALPGLLARSSAQARLNVERMDSEggRMNLALEG-QLADLLGWFESLG-RSGVEVTSLDLEVSPDA-------------
111 UniRef50_C9YDY7 Putative uncharacterized pr... 55 1e-06 1 11.8% 39:165 1:126 --------------------------------------MLTLAAVLVLGTLLWTVGIAPALRTVKAYPAQRGTLDAQLQSMQALQMRAQNLKGQPAVDGRAAQAALQSTVASLGTKANLLVI-GQQATVTFRGLDAAVLAQWLARARSEARLVPAQAKLSREGSS-------------
112 UniRef50_C6BWY4 ABC-type nitrate/sulfonate/... 55 1e-06 1 20.0% 22:166 1:172 ---------------------MNILLASWNKLDPRDRRALGICLIFLFSVVLYMGVLAPLGNMYEATVQEQVELKQEiaKLRQVKNEYESLKRQLDlsSSDIYNEIRDYATITGVVIKEMRpsSQPMDVTFSG-SFTAIEKFIYYLETSPQVFVVS-EISLTGKSG------------
113 UniRef50_Q1JVU6 Putative uncharacterized pr... 55 1e-06 1 17.8% 31:159 4:152 ------------------------------QLSPRELAMVLVAAIFVIATVIYLAMIAPYVATMERLDSKIASRQQQLQQAKELQqqIKSLQRRQASAGdyVESQVTRIAGRENLTSMRPMPaeEAVEIKLENVSLGQMLQLLQSFNSAppLQVKALQL-------------------
114 UniRef50_C4ZCH2 Putative uncharacterized pr... 54 2e-06 1 18.9% 32:105 1:74 -------------------------------MSTRDKKLLIILAGVAILALTYFLIFMPQSNKRDSLKSENMNLKSQYNQLSALAAKADDYTKKTKDMSDAMQQV-------------------------------------------------------------------------
115 UniRef50_Q6LM86 Hypothetical MSHA biogenesi... 54 2e-06 1 12.4% 22:158 4:133 ---------------------WQQLSDRFDLLTRREQILILVSGWVALLFVGFVVVIEPTMKDVTSIKRQLVSAANELVSSDNQIAAIN--RKLNSDPNNDVDKKIERLEQQTDGLNEQLT---DRVASLVTPIQMSGLME--EVLRRTTRLKLISLE--------------------
116 UniRef50_C5CPK5 Putative uncharacterized pr... 53 4e-06 1 12.0% 23:164 5:148 ----------------------EQLRARWAALELRERRMVAIAAALVVLALLWWVALAPALRTLAAAPADHAQLDAQLQQMAVLQNRAKALQAQPRLNRDDALRALETSVRelGTNAQLMTASGDgaTITMRATPADAVAQWLAQARGNAHAVPREAHLTRAAA--------------
117 UniRef50_B1I3E4 Putative uncharacterized pr... 53 4e-06 1 11.7% 29:105 2:78 ----------------------------WQNLSERQRLLVMVAATVLVFALLYLLVLSRQISAFQRAGAALEATSAELQQYRAKAARFEVEKEREAASQIRLEEL-------------------------------------------------------------------------
118 UniRef50_A9IRQ5 General secretion pathway p... 52 8e-06 1 18.0% 27:165 35:191 --------------------------SWYALRPRREQRLLACAGALLAAALVFLLLVEPAWSTMTRTRQELPDLRAQTATVAELTAQVRALRraGAATASPSPGELTASLRREGLpnAEAAAPASAIRLNLREASAAALFRWLDTAARDWRLSVADAELARATNP-------------
119 UniRef50_Q6FCM0 Putative uncharacterized pr... 52 1e-05 1 17.1% 15:172 9:159 --------------QLTLDQKLERLNEALERMSVRERYMVVFTTVFVVVVGVGWALWS-MHRLADEQQKRLTDLKDQMVWMQSNAVTMK----PQGEGQLSVAEKVQRISQQQGLSVSSQQ-VGEQLQIVAEHQSYAVLANFLMQL-SQMGLSVEKMELVSANNQIKLTATV------
120 UniRef50_A7C5U9 Putative uncharacterized pr... 50 3e-05 1 23.4% 100:176 2:80 ---------------------------------------------------------------------------------------------------QSLLNLIDKSTRIGALRNANKQIEaqEVRVNFEEVSFTDLMRWLGQLYNQHQIQVSTMSIEQKHKPNKVKV-RLTLK--
121 UniRef50_UPI00016990A6 hypothetical protein Epers_... 49 7e-05 1 18.4% 25:122 1:103 ------------------------MIRWFYAKPPRERLALLTGGASLLILLIYLLVWTPFISKLERKQAQLESQRATLAWLQSAVSEVAQLRAAQpkTNESLFTLVDRTATQNRLRKQIDQI--------------------------------------------------------
122 UniRef50_B9NKA7 Predicted protein (Fragment... 47 2e-04 1 13.0% 39:130 1:92 --------------------------------------MTLLAGGVVALALLWWVALAPALHSLRTAPERHAQADRQLRQMQLLQAEAEQLRGNARPVVGDAKALLQSSLSAELGASAQLNWMGDRAQIT------------------------------------------------
123 UniRef50_A7C5V0 Putative uncharacterized pr... 44 0.002 1 28.6% 27:68 2:43 --------------------------NWFKQLAPHERRTLMIGTIALSSLLFYFLIWEPFVTARTQLE--------------------------------------------------------------------------------------------------------------
124 UniRef50_C0QLC7 PilO n=1 Tax=Desulfobacteri... 52 1e-05 1 14.1% 16:171 28:208 ---------------AKIGKKTAPIFEKIGDLSMVQRILVCLITIVLVIGGYVYFIYMPKQERMEKLENKLASLKRTLVTYRQKAATLEKYEKKMADAQasLLTGISSSGSDAGLEFLLFQPKGQVDKEFYAEIpyHEIAAFFDQVARLYRIviDNITMTSQNKSDDLEAS-------
125 UniRef50_B4S2I3 Putative Mannose-sensitive ... 48 9e-05 1 13.1% 19:163 1:138 ------------------MSQYQQLSEKFSALEGREKQLILWVSFGLIVYLFFWFGILPALDDLSTADKAVKRKSSEYN---ALVIQRDAVQQALSIDYTQRTQQELDSARKALLAI-----DEELLSLNEGFVAADRMPELLMtlNEENNVRLVNFNVEPTQ---------------
126 UniRef50_D0Z1S9 MSHA biogenesis protein Msh... 48 1e-04 1 12.3% 21:158 3:133 --------------------QWQQLDQKFAALSLREKWLITGCGFVAIFFVGIFTFIQPLMADADSAHLSTLDVKNQ---VITANNQVIVLNNKLKEDPDA----------KINVNIAKLQHQETQLKLELDkiTPQQMPALlhVLQQSASLHLVSME--------------------
127 UniRef50_A4G6F4 Putative uncharacterized pr... 47 2e-04 1 13.2% 18:146 1:121 -----------------MKQAWHKLALKIDAMSLRERVIIFAIAVLILVLLINAALLDPQYAKQSKLSQQIKEQQAQIADIQNQIQQRVKAQANDPDYDVRVRMQALRQ------RAQQMNDALGDVQKGL--VPPDRMAALLESV--------------------------------
128 UniRef50_Q12IV1 MSHA biogenesis protein Msh... 47 3e-04 1 13.9% 18:175 1:151 -----------------MKQQWQALASKFNELSQRERVLVGFASLVLVVFSCFMLL-EPMLL---DNQQRAQHLKELHHSNQMASQSIAVYQQGLSLDPDADYKQ-----RLAMLEQQLIFVDAELSEQMVDMIPADYMPAVLAQLLSqkGLTLLGFSSLPPQalGSEEVNKLNL---
129 UniRef50_Q1K1Y8 Putative uncharacterized pr... 46 5e-04 1 11.7% 20:164 6:143 -------------------SLLDKVKGWFAALNKREQRLIVGTLFGAPLFVFIQLIFLPGLTEQTALERQVHQLEQDNTILQSQVLEMSLLAEKDPDADN------RKKLEQLQQEIARF---DQRLQENLSgvAPAQMPGLlsMLKQRAGLTLISMENAQPQA--------------
130 UniRef50_Q21LN4 Putative uncharacterized pr... 45 9e-04 1 12.8% 15:163 2:143 --------------KALLQQKWALLAVKINARNTRERALIAVSCWAMIYLVWDFAFFQPLNKQKEALQQRFDATNQTLVQLDAQQQVFVRALSSDPNAG--------RRREIVALKESITVLDNEINRLSDGLIPAPKLPQLLHdlRANNNLKLVSMRTQPAE---------------
131 UniRef50_A0YA33 Hypothetical MSHA biogenesi... 44 0.002 1 12.3% 18:90 1:73 -----------------MNEKFAEWKSKFDVLAQRERILLLVCAAVVTIMLMQVVLLDPLLGTSKKISSRAAEASGKISRYQAEKQVVEA----------------------------------------------------------------------------------------
132 UniRef50_Q7VH54 Putative uncharacterized pr... 44 0.002 1 15.0% 19:165 14:190 ------------------QAIQKAFEHFLATKTTREKYFLAATIVLCVCFIVIDFIYLPLLEKYSALSrqSQNIQEKLRITQENIALIQSYLKENTKepFALMSELINFAKTHQLSLSSFSPHATLDALGIEGmsFEEIVALIYFIESHRFFSVDTLSFKPFNDA-------------
133 UniRef50_C5EYM4 Predicted protein n=1 Tax=H... 43 0.004 1 11.8% 18:161 1:164 -----------------MKEILKKIESFLETKSKREMILIFVLAFLCFFTLTFMLIYDRAWNYFLTIKQTKLDLERQLLSLQEqkSEIQKLEDsqEKQKERLQGNFNHFLALNHLGKKYfqQEGEEFLLYGEG-NFKEAFLFLEELENLQMLEIKGASIYP-----------------
134 UniRef50_A9GDP3 Putative uncharacterized pr... 43 0.004 1 14.9% 25:125 3:109 ------------------------LRERLDKLEPRERRLLTILLGFLAVIVLLLvgLASVASSKRAENQEIRDLLQSIYEASGKVSERKALkaRYARPAPALAGFIEDAAKQQQLTAAESQDRPD-----------------------------------------------------
135 UniRef50_C6WW12 Putative mannose-sensitive ... 43 0.005 1 16.6% 25:169 12:147 ------------------------LSNKVESLNQRERLMVLGAAALLTYTVMQMLLLDSLETHKKRLLTEISTDQALVQELQQQTALYIN--KPPIDPDAQNKERIAE------LNTQLQALKSAQSQLDVSLISPEKMPELLRDLLSKNG-KLKLIALNTLPTQNIVE---------
136 UniRef50_C5BR21 MSHA biogenesis protein, Ms... 42 0.008 1 13.3% 15:164 3:145 --------------RDHLLKRWAQWQAQFSKLSFRERILAGAGVFGLLLMAWHFAFLAPAISEQERLQQRFEQAQKELKSL--------GMEEQALVSAMSSDPSLVLRKRVDNLQAELNALDQHVQQMSAGLISAQRLPELLQalKETSGLELVAMRIAAPQK--------------
137 UniRef50_B8FH98 Pilus assembly protein PilO... 42 0.008 1 10.5% 31:125 20:130 ------------------------------QLSRPQRILIFVAAFLVIGALFTFLLFKPYWTQKSELTTKLENKLNEVRVSQAKAAKLPKVREQRKKAEERLAKSAEssGKEAGLEWTLFQPRSE-----------------------------------------------------
138 UniRef50_A6FG32 Glucose-6-phosphate isomera... 42 0.009 1 12.0% 18:150 2:126 -----------------MKQHWLTINDKFRQLSMRERILIVVSLVASVIYVIDSFVLAPNYARHKQLTSQLSSLGQQQ---RQHGFTLAELQRVLATDPNKVIKL--RILRAEN---TLKKANGKLTDLTADLINSNQMALVLGDVLSRA----------------------------
139 UniRef50_Q1QBS3 Putative uncharacterized pr... 42 0.011 1 15.1% 16:161 22:170 ---------------ARMTGYQNLLFVRWQALSSRDQLALLLLSAFLLLFIGGYGGYS-IHQAANHSKSEYQEQVADYFWLRAQAGNIDSNALAAANTTdpATSSVNALLTNSGIVDAQVIANGNTVQLSFNNPSQAVVSAALGKLE-QQGWQFTQLSMQQ-----------------
140 UniRef50_D1UBZ2 Putative uncharacterized pr... 42 0.014 1 16.3% 12:177 14:175 -----------RAKRHFWSGWPEGSRQRLFRLAPR-----GTALVCLSVFIGLRLLVGSVTTQIEESKAQYARVLPLVEEILTLRAQRGDLAH--LPPDKAVWRIIDDLSIEQNLISMRETGLGEdlQTTLTGLPLNTLARFLNDLRDRASLQTRDCALTRNPDDPRLSDAHLVLAR-
141 UniRef50_C6Q655 Putative uncharacterized pr... 41 0.022 1 11.9% 32:165 3:113 -------------------------------LTKRERVLIYFAIVLGFLALYYQYYLAPKILEIQNLSVELKSKKQILEQVAAL-------------NNKSLKEGLEKQQTQLK-ELSMILPEERDIEIFL----FN-----LQQMVNDTGVKTKSLAFGNPDQP-------------
142 UniRef50_Q8RAE9 Fimbrial assembly protein n... 41 0.022 1 15.9% 32:138 3:109 -------------------------------LTKREKFLIYFALVFAFFAIYYQFYLIPKLSEIDNLSQEIKLKRQILSQVSSLKGelQKSLAKWEKEVEELNAIleKDAEFAILDLQRMASDSG---VKIRSINFEN----------------------------------------
143 UniRef50_C1I9R4 Type IV pilus assembly prot... 40 0.025 1 14.1% 31:94 2:65 ------------------------------NISKREKYLIGILLTVLICFVYYQFIYTKQVGKLATKRAEKNQVEQRYNDVMDNISKLDSKEEN------------------------------------------------------------------------------------
144 UniRef50_Q2S973 Putative uncharacterized pr... 40 0.026 1 17.6% 22:157 2:130 ---------------------MKKWISRVNRFSVRERGILLATVVVALILLYAQFAWEPLWRSNRSAEQAIAAANLELVDLSAQTD---VLRKQLAQDPDAALRKENERLR-NQLNARQERLKQNLSRLVAPEEMPELLMALLHK---HPGLQVVAV---------------------
145 UniRef50_B9Y7Z6 Putative uncharacterized pr... 40 0.028 1 15.6% 32:108 3:79 -------------------------------LSEREKILLVVLAFMLLNVVGIQFLLTPMQKKHEELINERTQIEDELAQQQLMIDMLDALNQDHEDLVVQLQNLADR----------------------------------------------------------------------
146 UniRef50_A7A8R5 Putative uncharacterized pr... 40 0.029 1 10.9% 38:138 8:110 -------------------------------------WIALAVGIVVVLMLTWLVGVSPRLTHIKEADAQTAQIEESNKKTRDQIETLRMASETIGLQKDRLRQLQRQIPDGYNQniDSLNAAADGAGVSIQSVTFDE----------------------------------------
147 UniRef50_UPI00016990A5 hypothetical protein Epers_... 40 0.033 1 29.3% 131:171 1:41 ----------------------------------------------------------------------------------------------------------------------------------MENAAFDAMLRWLGLLQQQYRIQVVSMNIDSKDKPGRINAR-------
148 UniRef50_B0TEG2 Putative uncharacterized pr... 40 0.034 1 22.9% 22:104 1:83 ---------------------MEGLLDWLERRTRREQALFLIAALTLFAAFAYRLFFEPLWQQYRLHAERLRSAQAMTEQLRRHQAEPGQADAPEAESLRALSA--------------------------------------------------------------------------
149 UniRef50_B4D3W8 Putative uncharacterized pr... 39 0.060 1 17.9% 17:133 209:329 ----------------SLTAILTTLPVWWHLFDRREKFLRRFAMAVIPMCAAWLLLWMPNERYAENDARRLTFLPASLFTIhqLANDLAANDPAVPYSHEQLQSIL--TLLDHEIELSRPTVRHGFAPLGFNP---------------------------------------------
consensus/100% ..................................................................................................................................................................................
consensus/90% ..............h..h..p-p.hhhhhhhhhh.hhhh.hhh.s..t..tt..tt..t..t....h.................................................................................................
consensus/80% .........h..hhtths.REphhlhhhhhhhhhhhhh.hhh.Ph.pthtphptph.t.tt.ht.htt....h.thttt.......h.thhtt.ht..th..t..t..tt.hth.ht.h..tth..hl..h..t..h.h..hth.................
consensus/70% .......h.thatths.REphhlhhhshhlhhhlhahhlhtPh.pthpphptphtphptpht.hpt.ttphtthttt.s.sstsl.thlppthtt.tlthtthp.pspthpl.hpthshtthhtaLttlttp.tltl.thpht...............
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown